Canadian Digestive Health Foundation Public Impact Series 3: Irritable Bowel Syndrome in Canada. Incidence, Prevalence, and Direct and Indirect Economic Impact
Open accessThe DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
The Canadian Digestive Health Foundation initiated a scientific program to assess the incidence, prevalence, mortality and economic impact of digestive disorders across Canada in 2009. The current article presents the updated findings from the study concerning irritable bowel syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






















Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Canadian Institute for Health Information.
Lalonde, A. (1994) · PubMed · Cited by 4,739
Drossman, D. A., Li, Z., Andruzzi, E., Temple, R. D., Talley, N. J., Grant Thompson, W., Whitehead, W. E., Janssens, J., Funch-Jensen, P., Corazziari, E., et al. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01303162 · Cited by 2,198 · cited 2×
“Three other studies examining the prevalence of IBS in the United States and Canada (22-25) reported a mean rate of 15.”
BackgroundInfluentialIrritable bowel syndrome in the general population.
Jones, R., & Lydeard, S. (1992) · BMJ · doi:10.1136/bmj.304.6819.87 · Cited by 636
Abdominal pain and irritable bowel syndrome in adolescents: a community-based study
Hyams, J. S., Burke, G., Davis, P. M., Rzepski, B., & Andrulonis, P. A. (1996) · The Journal of Pediatrics · doi:10.1016/s0022-3476(96)70246-9 · Cited by 532
THABANE, M., KOTTACHCHI, D. T., & MARSHALL, J. K. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03399.x · Cited by 466
Physical Activity Improves Symptoms in Irritable Bowel Syndrome: A Randomized Controlled Trial
Johannesson, E., Simrén, M., Strid, H., Bajor, A., & Sadik, R. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.480 · Cited by 431 · cited 1×
“The mainstay of therapy has been involving IBS patients in supportive therapeutic alliance and promoting healthy living (eg, lifestyle and dietary changes, physical exercise) (3,42,43).”
BackgroundMarshall, J. K., Thabane, M., Garg, A. X., Clark, W. F., Salvadori, M., & Collins, S. M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.05.053 · Cited by 375
Thompson, W. G., Irvine, E. J., Pare, P., Ferrazzi, S., & Rance, L. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1013208713670 · Cited by 327
Talley, N. J., Zinsmeister, A. R., & Melton, L. J. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117548 · Cited by 327
Symptom complaints and health care seeking behavior in subjects with bowel dysfunction
Sandler, R. S., Drossman, D. A., Nathan, H. P., & McKee, D. C. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90706-6 · Cited by 326
Elsenbruch, S. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.11.010 · Cited by 279
MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome
Zhou, Q., Souba, W. W., Croce, C. M., & Verne, G. N. (2010) · Gut · doi:10.1136/gut.2009.181834 · Cited by 277
Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives
Salonen, A., de Vos, W. M., & Palva, A. (2010) · Microbiology · doi:10.1099/mic.0.043257-0 · Cited by 264
Costs of Irritable Bowel Syndrome in the UK and US
Maxion-Bergemann, S., Thielecke, F., Abel, F., & Bergemann, R. (2006) · PharmacoEconomics · doi:10.2165/00019053-200624010-00002 · Cited by 263
Keohane, J., O'Mahony, C., O'Mahony, L., O'Mahony, S., Quigley, E. M., & Shanahan, F. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.156 · Cited by 253
Impact of Functional Gastrointestinal Disorders on Survival in the Community
Chang, J. Y., Locke, R. G., McNally, M. A., Halder, S. L., Schleck, C. D., Zinsmeister, A. R., & Talley, N. J. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.40 · Cited by 237
Meta‐analysis: factors affecting placebo response rate in the irritable bowel syndrome
Ford, A. C., & Moayyedi, P. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04328.x · Cited by 226
Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome
Malinen, E. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i36.4532 · Cited by 218
Grundmann, O., & Yoon, S. L. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06120.x · Cited by 209
KAY, L., JØRGENSEN, T., & JENSEN, K. H. (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb01115.x · Cited by 193
The economic impact of irritable bowel syndrome
Inadomi, J. M., Fennerty, M. B., & Bjorkman, D. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.t01-1-01736.x · Cited by 190
Functional Gastrointestinal Disorders in Children: An Italian Prospective Survey
Miele, E., Simeone, D., Marino, A., Greco, L., Auricchio, R., Novek, S. J., & Staiano, A. (2004) · Pediatrics · doi:10.1542/peds.114.1.73 · Cited by 177
Familial Aggregation of Irritable Bowel Syndrome: A Family Case–Control Study
Saito, Y. A., Petersen, G. M., Larson, J. J., Atkinson, E. J., Fridley, B. L., de Andrade, M., Locke, R. G., Zimmerman, J. M., Almazar, A. E., & Talley, N. J. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.116 · Cited by 154
Maxwell, P., Mendall, M., & Kumar, D. (1997) · The Lancet · doi:10.1016/s0140-6736(97)05276-8 · Cited by 133
Sperber, A. D., Shvartzman, P., Friger, M. D., & Fich, A. (2007) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32801140e2 · Cited by 128
Thabane, M., Simunovic, M., Akhtar-Danesh, N., Garg, A. X., Clark, W. F., Collins, S. M., Salvadori, M., & Marshall, J. K. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.74 · Cited by 120
Dong, L., Dingguo, L., Xiaoxing, X., & Hanming, L. (2005) · Pediatrics · doi:10.1542/peds.2004-2764 · Cited by 94
O’Mahony, S. M., Bulmer, D. C., Coelho, A.-M., Fitzgerald, P., Bongiovanni, C., Lee, K., Winchester, W., Dinan, T. G., & Cryan, J. F. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01432.x · Cited by 90
Sperber, A. D., & Dekel, R. (2010) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2010.16.2.113 · Cited by 85 · cited 1×
“Overlap of symptoms with other gastrointestinal disorders (eg, gastroesophageal reflux disease, dyspepsia and inflammatory bowel diseases), a wide range of symptoms and extensive comorbid conditions (eg, fibromyalgia and chronic fatigue) adds to the complexity of identifying the underlying cause for IBS (3,10,11).”
BackgroundIncidence of a clinical diagnosis of the irritable bowel syndrome in a United States population
Locke, G. R., Yawn, B. P., Wollan, P. C., Melton, L. J., LYDICK, E. G., & Talley, N. J. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01938.x · Cited by 85
Irritable bowel syndrome in France: quality of life, medical management, and costs: the Encoli study
Brun-Strang, C., Dapoigny, M. C., Lafuma, A., Wainsten, J.-P., & Fagnani, F. (2007) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3282f1621b · Cited by 78
Paterson, W. G., Thompson, W., Vanner, S., Faloon, T., Rosser, W. W., Birtwhistle, R., Morse, J. L., & Touzel, T. A. (1999) · Europe PMC (PubMed Central) · Cited by 71
Self-citationÓlafsdóttir, L. B., Gudjonsson, H., Jónsdóttir, H. H., & Þjóðleifsson, B. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04388.x · Cited by 69
Trauma history and risk of the irritable bowel syndrome in women veterans
White, D. L., Savas, L. S., Daci, K., El‐Serag, R., Graham, D. P., Fitzgerald, S. J., Smith, S. L., Tan, G., & El‐Serag, H. B. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04387.x · Cited by 69
Spiegel, B. M. R., Kanwal, F., Naliboff, B. D., & Mayer, E. A. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00269.x · Cited by 69
Li, F. X., Patten, S. B., Hilsden, R. J., & Sutherland, L. R. (2003) · Canadian Journal of Gastroenterology · doi:10.1155/2003/706891 · Cited by 62
Johansson, P. A., Farup, P. G., Bracco, A., & Vandvik, P. O. (2010) · BMC Gastroenterology · doi:10.1186/1471-230x-10-31 · Cited by 61
Herman, J. R., Pokkunuri, V. B., Braham, L., & Pimentel, M. (2010) · Gender Medicine · doi:10.1016/j.genm.2010.06.007 · Cited by 58
Unexpectedly low prevalence rates of IBS among adult Israeli Jews
Sperber, A. D., Shvartzman, P., Friger, M. D., & Fich, A. (2005) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2005.00623.x · Cited by 48
The Incidence of Abdominal and Pelvic Surgery Among Patients with Irritable Bowel Syndrome
Cole, J. A., Yeaw, J. M., Cutone, J. A., Kuo, B., Huang, Z., Earnest, D. L., & Walker, A. M. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-3047-1 · Cited by 44
Lix, L. M., Yogendran, M. S., Shaw, S. Y., Targownik, L. E., Jones, J., & Bataineh, O. M. (2010) · BMC Health Services Research · doi:10.1186/1472-6963-10-31 · Cited by 34
The Economic Burden of Irritable Bowel Syndrome in Canada
Bentkover, J. D., Field, C., Greene, E. M., Plourde, V., & Casciano, J. P. (1999) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/1999/569613 · Cited by 32
Socioeconomic Impact of Irritable Bowel Syndrome in Canada
Boivin, M. (2001) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2001/401309 · Cited by 31
Reshetnikov, O. V., Kurilovich, S. A., Вахтанговна, Д. Д., Георгиевна, З. Л., & Tereshonok, I. N. (2001) · International Journal of Circumpolar Health · doi:10.1080/25761900.2022.12220600 · Cited by 30
Is irritable bowel syndrome associated with chronic hepatitis C?
Fouad, Y. M., Makhlouf, M. M., Khalaf, H., Mostafa, Z., Abdel-Raheem, E. M., & Meneasi, W. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06311.x · Cited by 15
Systematic review: the economic impact of irritable bowel syndrome
Jorkman, D. B. (2003) · Cited by 15
The economic burden of irritable bowel syndrome in Canada
Bentkover, J., Field, C. E., Greene, E., Plourde, V., & Casciano, J. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)82956-9 · Cited by 10
Physical Activity Improves Symptoms in Irritable Bowel Syndrome: A Randomized Controlled Trial
Talley, N. J. (2011) · Yearbook of Medicine · doi:10.1016/s0084-3873(11)00322-1 · Cited by 8
Research works printed but not linked: 4
- O'Mahony SM, Bulmer DC, Coelho AM, et al. 5-HT(2B) receptors modulate visceral hypersensitivity in a stress-sensitive animal model of brain-gut axis dysfunction. Neurogastroenterol Motil 2010;22:573-8, e124.
- Saito YA, Petersen GM, Larson JJ, et al. Familial aggregation of irritable bowel syndrome: A family case-control study. Am J Gastroenterol 2010;105:833-41.
- Statistics Canada. CANSIM -Table 102-0531 -Deaths, by cause, Chapter XI: Diseases of the digestive system (K00 to K93), age group and sex, Canada, annual (2000-2006). <http://cansim2. statcan.gc.ca> (Accessed July 28, 2010).
- Paterson WG, Thompson WG, Vanner SJ, et al. Recommendations for the management of irritable bowel syndrome in family practice. CMAJ 1999;161:154-60.
Cited by
Creed, F. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15396 · Cited by 98
Eskesen, D., Jespersen, L., Michelsen, B., Whorwell, P. J., Müller-Lissner, S., & Morberg, C. M. (2015) · British Journal of Nutrition · doi:10.1017/s0007114515003347 · Cited by 78
“We observed very high placebo response rates in this study, although similar placebo effects have previously been reported in both healthy subjects and IBS patients((17,25,26,33)).”
ResultLowe, C., Aiken, A. B., Day, A. G., Depew, W. T., & Vanner, S. J. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.13040 · Cited by 50
Self-citationSilvester, J. A., Graff, L. A., Rigaux, L. N., Bernstein, C. N., Leffler, D. A., Kelly, C. P., Walker, J. R., & Duerksen, D. R. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4666-z · Cited by 45
An approach to the care of patients with irritable bowel syndrome
Farmer, A. D., Wood, E., & Ruffle, J. K. (2020) · Canadian Medical Association Journal · doi:10.1503/cmaj.190716 · Cited by 35
Metadata
- Authors
- Fedorak, R. N., Vanner, S. J., Paterson, W. G., & Bridges, R. J.
- Affiliations
- University of Alberta (CA)
- Queen's University (CA)
- University of Calgary (CA)
- Corresponding author
- Fedorak, Richard N
- Venue
- Canadian Journal of Gastroenterology
- Publisher
- Hindawi Limited
- Published
- 2012
- Volume
- 26
- Issue
- 5
- Pages
- 252-256
- ISSN
- 0835-7900 (ISSN-L)
- PMC
- PMC3352839
- OpenAlex
- W162570380
- Cited by
- 18
- References
- 49
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 3 · 2017: 2 · 2015: 1 · 2013: 1
- FWCI
- 0.62
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Canadian Journal of Gastroenterology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Keywords
- irritable bowel syndrome, incidence, prevalence, economic burden, direct and indirect costs, gastrointestinal diseases, Canada
- MeSH terms
- Canada, Employment, Hospitalization, Humans, Comorbidity, Incidence, Prevalence, Cost of Illness, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.